Literature DB >> 9971864

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

P C Hébert1, G Wells, M A Blajchman, J Marshall, C Martin, G Pagliarello, M Tweeddale, I Schweitzer, E Yetisir.   

Abstract

BACKGROUND: To determine whether a restrictive strategy of red-cell transfusion and a liberal strategy produced equivalent results in critically ill patients, we compared the rates of death from all causes at 30 days and the severity of organ dysfunction.
METHODS: We enrolled 838 critically ill patients with euvolemia after initial treatment who had hemoglobin concentrations of less than 9.0 g per deciliter within 72 hours after admission to the intensive care unit and randomly assigned 418 patients to a restrictive strategy of transfusion, in which red cells were transfused if the hemoglobin concentration dropped below 7.0 g per deciliter and hemoglobin concentrations were maintained at 7.0 to 9.0 g per deciliter, and 420 patients to a liberal strategy, in which transfusions were given when the hemoglobin concentration fell below 10.0 g per deciliter and hemoglobin concentrations were maintained at 10.0 to 12.0 g per deciliter.
RESULTS: Overall, 30-day mortality was similar in the two groups (18.7 percent vs. 23.3 percent, P= 0.11). However, the rates were significantly lower with the restrictive transfusion strategy among patients who were less acutely ill -- those with an Acute Physiology and Chronic Health Evaluation II score of < or =20 (8.7 percent in the restrictive-strategy group and 16.1 percent in the liberal-strategy group; P=0.03) -- and among patients who were less than 55 years of age (5.7 percent and 13.0 percent, respectively; P=0.02), but not among patients with clinically significant cardiac disease (20.5 percent and 22.9 percent, respectively; P=0.69). The mortality rate during hospitalization was significantly lower in the restrictive-strategy group (22.3 percent vs. 28.1 percent, P=0.05).
CONCLUSIONS: A restrictive strategy of red-cell transfusion is at least as effective as and possibly superior to a liberal transfusion strategy in critically ill patients, with the possible exception of patients with acute myocardial infarction and unstable angina.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971864     DOI: 10.1056/NEJM199902113400601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  886 in total

1.  Reducing the risk of major elective surgery. Paper should have given details on causes of death.

Authors:  S Sudhindran
Journal:  BMJ       Date:  1999-11-20

2.  Critical haemoglobin thresholds in premature infants.

Authors:  C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 3.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

4.  Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial.

Authors:  Julian C L Wong; Francesco Torella; Sarah L Haynes; Kirsteen Dalrymple; Andrew J Mortimer; Charles N McCollum
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 5.  Autologous transfusion.

Authors:  Elizabeth S Vanderlinde; Joanna M Heal; Neil Blumberg
Journal:  BMJ       Date:  2002-03-30

6.  Why is it important to reduce the need for blood transfusion, and how can it be done?

Authors:  Abi Berger
Journal:  BMJ       Date:  2002-06-01

Review 7.  Pathology tests: is the time for demand management ripe at last?

Authors:  G Gopal Rao; M Crook; M L Tillyer
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 8.  Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis.

Authors:  Teresa C Rice; Amanda M Pugh; Charles C Caldwell; Barbara St Pierre Schneider
Journal:  Crit Care Nurs Clin North Am       Date:  2017-06-23       Impact factor: 1.326

9.  A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.

Authors:  Laura E Fredenburgh; Mark A Perrella; Diana Barragan-Bradford; Dean R Hess; Elizabeth Peters; Karen E Welty-Wolf; Bryan D Kraft; R Scott Harris; Rie Maurer; Kiichi Nakahira; Clara Oromendia; John D Davies; Angelica Higuera; Kristen T Schiffer; Joshua A Englert; Paul B Dieffenbach; David A Berlin; Susan Lagambina; Mark Bouthot; Andrew I Sullivan; Paul F Nuccio; Mamary T Kone; Mona J Malik; Maria Angelica Pabon Porras; Eli Finkelsztein; Tilo Winkler; Shelley Hurwitz; Charles N Serhan; Claude A Piantadosi; Rebecca M Baron; B Taylor Thompson; Augustine Mk Choi
Journal:  JCI Insight       Date:  2018-12-06

Review 10.  Red blood cell storage time and transfusion: current practice, concerns and future perspectives.

Authors:  María García-Roa; María Del Carmen Vicente-Ayuso; Alejandro M Bobes; Alexandra C Pedraza; Ataúlfo González-Fernández; María Paz Martín; Isabel Sáez; Jerard Seghatchian; Laura Gutiérrez
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.